Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BioHiTech Global stock

Own BioHiTech Global stock in just a few minutes.

BioHiTech Global, Inc is a pollution & treatment controls business based in the US. BioHiTech Global shares (BHTG) are listed on the NASDAQ and all prices are listed in US Dollars. BioHiTech Global employs 42 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in BioHiTech Global

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BHTG – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BioHiTech Global share price

Use our graph to track the performance of BHTG stocks over time.

BioHiTech Global shares at a glance

Information last updated 2021-04-30.
52-week range$1.05 - $3.20
50-day moving average $1.59
200-day moving average $1.53
Wall St. target price$5.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.58

Buy BioHiTech Global shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioHiTech Global stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioHiTech Global financials

Revenue TTM $5.9 million
Gross profit TTM $226,403
Return on assets TTM -11.81%
Return on equity TTM -258.54%
Profit margin -196.25%
Book value $-0.22
Market capitalisation $42.1 million

TTM: trailing 12 months

Shorting BioHiTech Global shares

There are currently 486,721 BioHiTech Global shares held short by investors – that's known as BioHiTech Global's "short interest". This figure is 19.8% up from 406,305 last month.

There are a few different ways that this level of interest in shorting BioHiTech Global shares can be evaluated.

BioHiTech Global's "short interest ratio" (SIR)

BioHiTech Global's "short interest ratio" (SIR) is the quantity of BioHiTech Global shares currently shorted divided by the average quantity of BioHiTech Global shares traded daily (recently around 2.4 million). BioHiTech Global's SIR currently stands at 0.2. In other words for every 100,000 BioHiTech Global shares traded daily on the market, roughly 200 shares are currently held short.

However BioHiTech Global's short interest can also be evaluated against the total number of BioHiTech Global shares, or, against the total number of tradable BioHiTech Global shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioHiTech Global's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 BioHiTech Global shares in existence, roughly 20 shares are currently held short) or 0.0201% of the tradable shares (for every 100,000 tradable BioHiTech Global shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BioHiTech Global.

Find out more about how you can short BioHiTech Global stock.

BioHiTech Global share dividends

We're not expecting BioHiTech Global to pay a dividend over the next 12 months.

BioHiTech Global share price volatility

Over the last 12 months, BioHiTech Global's shares have ranged in value from as little as $1.05 up to $3.2. A popular way to gauge a stock's volatility is its "beta".

BHTG.US volatility(beta: 1.29)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioHiTech Global's is 1.2907. This would suggest that BioHiTech Global's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioHiTech Global overview

BioHiTech Global, Inc. , through its subsidiaries, provides technological, biological, and mechanical engineering solutions of organic and municipal waste worldwide. Its suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. The company also markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and High Efficiency Biological Treatment Resource Recovery Technology to process waste at the municipal or enterprise level. In addition, it offers BioHiTech Cloud and Cirrus mobile applications for digester customers. Its principal customers include producers of food waste. The company serves healthcare, grocery, prison, retail food service, education, and hospitality sectors, as well as food distributors, convention centers, hotels, restaurants, stadiums, municipalities and academic institutions, and stadiums.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site